您好！歡迎訪問上海起發(fā)實(shí)驗(yàn)試劑有限公司網(wǎng)站！
全國服務(wù)咨詢熱線:
15921799099
15921799099
簡(jiǎn)要描述：R&D代理，R&D上海代理，R&D北京代理，R&D 總代理，R&D一級(jí)代理，R&D國內(nèi)代理上海起發(fā)實(shí)驗(yàn)試劑有限公司R&D專業(yè)代理，具體產(chǎn)品信息歡迎電詢：4006551678
產(chǎn)品型號(hào)：廠商性質(zhì)：代理商更新時(shí)間：2026-01-02訪 問 量：4228產(chǎn)品分類
Product Category詳細(xì)介紹
R&D代理，R&D上海代理，R&D北京代理，R&D 總代理，R&D一級(jí)代理，R&D國內(nèi)代理
上海起發(fā)實(shí)驗(yàn)試劑有限公司R&D專業(yè)代理，具體產(chǎn)品信息歡迎電詢：
| R&D | 1404-TC-050/CF | Recombinant Mouse TrkC, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1405-UN-050 | Recombinant Rat UNC5H1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1406-ST-025 | Recombinant Human SOST (25 UG) | 25 UG | 4,150.00 |
| R&D | 1406-ST-025/CF | Recombinant Human SOST, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1407-PI-050 | Recombinant Human Cystatin A, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1408-PI-050 | Recombinant Human Cystatin B, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1409-PI-050 | Recombinant Mouse Cystatin B, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 141-B2-100 | Recombinant Human B7-2/CD86 Fc Chimera, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 1410-CR-050 | Recombinant Human Cryptic (50 UG) | 50 UG | 4,150.00 |
| R&D | 1410-CR-050/CF | Recombinant Human Cryptic, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 14110-1 | Recombinant Rhesus Macaque/Cynomologous IFN-alpha (100000 UN) | 100000 UN | 3,580.00 |
| R&D | 1413-FB-025 | Recombinant Rat FGF-BP (25 UG) | 25 UG | 3,320.00 |
| R&D | 1413-FB-025/CF | Recombinant Rat FGF-BP, CF (25 UG) | 25 UG | 3,320.00 |
| R&D | 142-DC-100 | Recombinant Human DcR3/TNFRSF6B Fc Chimera, CF (100 UG) | 100 UG | 4,490.00 |
| R&D | 1429-UN-050 | Recombinant Human UNC5H4 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 143-DE-100 | Recombinant Human Decorin, CF (100 UG) | 100 UG | 3,760.00 |
| R&D | 1430-CD-050 | Recombinant Human cd45, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1433-OP-050 | Recombinant Human Osteopontin (OPN) (50 UG) | 50 UG | 3,060.00 |
| R&D | 1433-OP-050/CF | Recombinant Human Osteopontin (OPN), CF (50 UG) | 50 UG | 3,060.00 |
| R&D | 1437-CD-050 | Recombinant Mouse CD83 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 144-DR-100 | Recombinant Human DR6/TNFRSF21 Fc Chimera, CF (100 UG) | 100 UG | 4,490.00 |
| R&D | 1440-NG-050 | Recombinant Mouse Nogo Receptor Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1445-PL-050 | Recombinant Mouse Prolactin (50 UG) | 50 UG | 3,760.00 |
| R&D | 1445-PL-050/CF | Recombinant Mouse Prolactin, CF (50 UG) | 50 UG | 3,760.00 |
| R&D | 1447-PC-025 | Recombinant Mouse PDGF-CC (25 UG) | 25 UG | 4,150.00 |
| R&D | 1447-PC-025/CF | Recombinant Mouse PDGF-CC, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 145-CR-010 | Recombinant Human Cripto-1 (10 UG) | 10 UG | 4,150.00 |
| R&D | 145-CR-010/CF | Recombinant Human Cripto-1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1454-ZN-010 | Recombinant Mouse Kell, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1458-HT-100 | Recombinant Human HTRA2/Omi, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 1459-S4-050 | Recombinant Mouse IGSF4A/SynCAM1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 146-IR-100 | Recombinant Human IL-13 R alpha 1 Fc Chimera, CF (100 UG) | 100 UG | 4,150.00 |
| R&D | 1460-CD-050 | Recombinant Mouse Fc gamma RIIB/CD32b, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 147-IR-100 | Recombinant Human IL-15 R alpha Fc Chimera, CF (100 UG) | 100 UG | 4,150.00 |
| R&D | 1470-PI-010 | Recombinant Human Serpin F2/alpha 2-Antiplasmin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1473-SE-010 | Recombinant Human Coagulation Factor II/Thrombin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1476-TR-050 | Recombinant Mouse TLR1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1477-AR-050 | Recombinant Mouse Activin RIB/ALK-4 Fc Chimera, CF (50 UG) | 50 UG | 4,280.00 |
| R&D | 1478-TR-050 | Recombinant Human TLR4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1479-TC-050 | Recombinant Human IL-27 Ra/WSX-1/TCCR Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 148-BC-100 | Recombinant Human BCAM Fc Chimera, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 1484-TR-050 | Recombinant Human TLR1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1487-TR-050 | Recombinant Human TLR3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1493-CD-050 | Recombinant Human CD40/TNFRSF5 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1494-TB-025 | Recombinant Mouse TrkB (25 UG) | 25 UG | 4,150.00 |
| R&D | 1494-TB-025/CF | Recombinant Mouse TrkB, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1503-SE-010 | Recombinant Human Furin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1504-IL-025 | Recombinant Human IL-17D (25 UG) | 25 UG | 4,150.00 |
| R&D | 1504-IL-025/CF | Recombinant Human IL-17D, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1505-LR-025 | Recombinant Human LRP-6 Fc Chimera, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1506-D4-050 | Recombinant Human DLL4 (50 UG) | 50 UG | 4,150.00 |
| R&D | 1506-D4-050/CF | Recombinant Human DLL4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1507-CT-025 | Recombinant Canine TNF-alpha (25 UG) | 25 UG | 4,150.00 |
| R&D | 1507-CT-025/CF | Recombinant Canine TNF-alpha, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1508-S1-025 | Recombinant Mouse Soggy-1/DkkL1 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1508-S1-025/CF | Recombinant Mouse Soggy-1/DkkL1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 15100-1 | Recombinant Feline IFN-alpha (100000 UN) | 100000 UN | 3,580.00 |
| R&D | 1513-ZN-010 | Recombinant Mouse ACE, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1514-SE-010 | Recombinant Human HGF Activator, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1515-CY-010 | Recombinant Mouse Cathepsin L, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1517-UL-050 | Recombinant Human ULBP-3 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1525-DC-050 | Recombinant Mouse Dectin-2/CLEC6A, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1529-TM-050 | Recombinant Mouse TIM-3 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1530-TR-050 | Recombinant Mouse TLR2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1533-TR-050 | Recombinant Mouse TLR6 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1534-LS-050 | Recombinant Rat L-Selectin/CD62L Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1535-LM-010 | Recombinant Mouse Limitin/IFN-zeta (10 UG) | 10 UG | 4,150.00 |
| R&D | 1535-LM-010/CF | Recombinant Mouse Limitin/IFN-zeta, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1538-CR-010 | Recombinant Mouse Cripto (10 UG) | 10 UG | 4,150.00 |
| R&D | 1538-CR-010/CF | Recombinant Mouse Cripto, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1539-PG-025 | Recombinant Mouse GDF-8 Propeptide (25 UG) | 25 UG | 4,150.00 |
| R&D | 1539-PG-025/CF | Recombinant Mouse GDF-8 Propeptide, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 154-AL-100 | Recombinant Human Axl Fc Chimera, CF (100 UG) | 100 UG | 4,490.00 |
| R&D | 1543-BP-025 | Recombinant Human BMP-3b/GDF-10 (25 UG) | 25 UG | 5,270.00 |
| R&D | 1543-BP-025/CF | Recombinant Human BMP-3b/GDF-10, CF (25 UG) | 25 UG | 5,270.00 |
| R&D | 1544-IR-050 | Recombinant Human Insulin R/CD220 (aa 28-944) (50 UG) | 50 UG | 4,150.00 |
| R&D | 1544-IR-050/CF | Recombinant Human Insulin R/CD220 (aa 28-944), CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1545-RA-025 | Recombinant Rat IL-1ra/IL-1F3 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1545-RA-025/CF | Recombinant Rat IL-1ra/IL-1F3, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1546-GM-025 | Recombinant Canine GM-CSF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1546-GM-025/CF | Recombinant Canine GM-CSF, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1548-TR-100 | Recombinant Human TROY/TNFRSF19 Fc Chimera, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 1549-S1-025 | Recombinant Human Soggy-1/DkkL1 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1549-S1-025/CF | Recombinant Human Soggy-1/DkkL1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1557-CD-050 | Recombinant Human CD320/TCblR/8D6A Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1559-NT-050 | Recombinant Human Notch-3 (aa 40-467) Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 156-B7-100 | Recombinant Human B7-H1 Fc Chimera, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 1563-PI-050 | Recombinant Mouse Fetuin A/AHSG, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1564-LX-050 | Recombinant Mouse LOX-1/OLR1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1568-HP-050 | Recombinant Mouse Hip (50 UG) | 50 UG | 4,150.00 |
| R&D | 1568-HP-050/CF | Recombinant Mouse Hip, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1569-PI-010 | Recombinant Human Kininogen HMW (HKa), CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 157-ER-100 | Recombinant Human EDAR Fc Chimera, CF (100 UG) | 100 UG | 4,490.00 |
| R&D | 1577-IL-010 | Recombinant Rhesus Macaque IL-4 (10 UG) | 10 UG | 3,890.00 |
| R&D | 1577-IL-010/CF | Recombinant Rhesus Macaque IL-4, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 1578-HC-025 | Recombinant Human CCL14a/HCC-1 (aa 28-93) (25 UG) | 25 UG | 4,150.00 |
| R&D | 1578-HC-025/CF | Recombinant Human CCL14a/HCC-1 (aa 28-93), CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 158-B7-100 | Recombinant Mouse B7-H2 Fc Chimera, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 1580-HS-050 | Recombinant Human HSP27, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1585-SE-010 | Recombinant Human Enteropeptidase/Enterokinase, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1586-HG-025 | Recombinant Equine IFN-gamma (25 UG) | 25 UG | 3,760.00 |
| R&D | 1586-HG-025/CF | Recombinant Equine IFN-gamma, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 1587-IL-025 | Recombinant Human IL-28A/IFN-lambda 2 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1587-IL-025/CF | Recombinant Human IL-28A/IFN-lambda 2, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1588-B1-025 | Recombinant Mouse IGFBP-1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1589-ST-025 | Recombinant Mouse SOST (25 UG) | 25 UG | 4,150.00 |
| R&D | 1589-ST-025/CF | Recombinant Mouse SOST, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 159-DP-020 | Recombinant Drosophila Decapentaplegic (Dpp) (20 UG) | 20 UG | 4,620.00 |
| R&D | 159-DP-020/CF | Recombinant Drosophila Decapentaplegic (Dpp) , CF (20 UG) | 20 UG | 4,620.00 |
| R&D | 1593-FB-025 | Recombinant Human FGF-BP, CF (25 UG) | 25 UG | 3,320.00 |
| R&D | 1595-SE-010 | Recombinant Human Kallikrein 11, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1596-B1-200 | Recombinant Rat EphB1 Fc Chimera, CF (200 UG) | 200 UG | 3,500.00 |
| R&D | 1597-FC-050 | Recombinant Human Fc gamma RIIIB/CD16b (50 UG) | 50 UG | 4,150.00 |
| R&D | 1597-FC-050/CF | Recombinant Human Fc gamma RIIIB/CD16b, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1598-IL-025 | Recombinant Human IL-29/IFN-lambda 1 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1598-IL-025/CF | Recombinant Human IL-29/IFN-lambda 1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1599-MB-050 | Recombinant Human MICB (aa 23-298) Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1600-R2-050 | Recombinant Mouse TGF-beta RII/(mouse) Fc Chimera, CF (50 UG) | 50 UG | 4,490.00 |
| R&D | 1603-CV-010 | Recombinant Canine VEGF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1603-CV-010/CF | Recombinant Canine VEGF, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1605-IL-010 | Recombinant Equine IL-10 (10 UG) | 10 UG | 3,890.00 |
| R&D | 1605-IL-010/CF | Recombinant Equine IL-10, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 1607-CD-050 | Recombinant Human CD163, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1608-CL-025 | Recombinant Canine CXCL8/IL-8 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1608-CL-025/CF | Recombinant Canine CXCL8/IL-8, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1609-CL-025 | Recombinant Canine IL-6 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1609-CL-025/CF | Recombinant Canine IL-6, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 161-DC-050 | Recombinant Human DC-SIGN/CD209 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1610-TW-050 | Recombinant Mouse TWEAK R/TNFRSF12 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1613-IL-020 | Recombinant Equine IL-2 (Cys141Ser) (20 UG) | 20 UG | 4,150.00 |
| R&D | 1613-IL-020/CF | Recombinant Equine IL-2 (Cys141Ser), CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1614-FL-025 | Recombinant Rat Fas Ligand/TNFSF6 (25 UG) | 25 UG | 4,360.00 |
| R&D | 1614-FL-025/CF | Recombinant Rat Fas Ligand/TNFSF6, CF (25 UG) | 25 UG | 4,360.00 |
| R&D | 1616-RG-050 | Recombinant Rat RAGE Fc Chimera, CF (50 UG) | 50 UG | 4,230.00 |
| R&D | 1617-FZ-050 | Recombinant Human Frizzled-5 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1617-FZC-050 | Recombinant Human Frizzled-5 Fc Chimera, CF (CHO-expressed) (50 UG) | 50 UG | 4,150.00 |
| R&D | 1618-MR-050 | Recombinant Rat MIS RII Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 162-D2-050 | Recombinant Human DC-SIGNR/CD299 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1627-WS-050 | Recombinant Human WISP-1/CCN4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1628-ZN-020 | Recombinant E. coli Methionine Aminopeptidase/METAP, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1629-AC-010 | Recombinant Human Activin C (10 UG) | 10 UG | 3,710.00 |
| R&D | 1629-AC-010/CF | Recombinant Human Activin C, CF (10 UG) | 10 UG | 3,710.00 |
| R&D | 1630-KS-010 | Recombinant Human Active Chk1, CF (10 UG) | 10 UG | 4,360.00 |
| R&D | 1635-T2-050 | Recombinant Human Thrombospondin-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1636-CD-050 | Recombinant Human CD5, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 164-SL-050 | Recombinant Human SLAM/CD150, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1640-NV-050 | Recombinant Human NOV/CCN3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1645-ZN-010 | Recombinant Human ECE-2, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1647-KR-025 | Recombinant Mouse Kremen-1 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1647-KR-025/CF | Recombinant Mouse Kremen-1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1649-CD-050 | Recombinant Human CDC25B (aa 377-566), CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 165-B7-100 | Recombinant Human B7-H2 Fc Chimera, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 1654-VH-050 | Recombinant Human VHR, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1667-SE-010 | Recombinant Human Tryptase gamma-1/TPSG1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1668-ZN-020 | Recombinant Human Pappalysin-2/PAPP-A2, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1669-PI-020 | Recombinant Human Serpin A4/Kallistatin, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1670-SE-020 | Recombinant E. coli HTRA/Protease Do, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1673-OM-025 | Recombinant Human OMgp, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1674-MG-025 | Recombinant Mouse OMgp, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 168-CS-100 | Recombinant Mouse ICOS Fc Chimera, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 1680-WS-050 | Recombinant Mouse WISP-1/CCN4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1686-MR-050 | Recombinant Mouse IL-23 R Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1687-CC-025 | Recombinant Human PDGF-CC (25 UG) | 25 UG | 4,150.00 |
| R&D | 1687-CC-025/CF | Recombinant Human PDGF-CC, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1688-AC-025 | Recombinant Human gAdiponectin/gAcrp30, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1689-CD-050 | Recombinant Human CD58/LFA-3 (50 UG) | 50 UG | 4,750.00 |
| R&D | 1689-CD-050/CF | Recombinant Human CD58/LFA-3, CF (50 UG) | 50 UG | 4,750.00 |
| R&D | 169-CS-050 | Recombinant Human ICOS Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1690-HM-025 | Recombinant Human HMGB1, CF (25 UG) | 25 UG | 4,800.00 |
| R&D | 1694-FN-050 | Recombinant Human Follistatin-like 1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1695-CR-050 | Recombinant Human CRTAM Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1696-CD-050 | Recombinant Mouse C1q R1/CD93 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1697-CR-025 | Recombinant Mouse CREG (25 UG) | 25 UG | 4,150.00 |
| R&D | 1697-CR-025/CF | Recombinant Mouse CREG, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1704-CL-050 | Recombinant Human CLEC-1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1705-HH-025 | Recombinant Human/Mouse Indian Hedgehog/Ihh (C28II) N-Term (25 UG) | 25 UG | 4,150.00 |
| R&D | 1705-HH-025/CF | Recombinant Human/Mouse Indian Hedgehog (C28II) N-Term, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1706-SF-050 | Recombinant Mouse Siglec-F Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1707-CR-200 | Recombinant Human C-Reactive Protein/CRP (200 UG) | 200 UG | 3,060.00 |
| R&D | 1707-CR-200/CF | Recombinant Human C-Reactive Protein/CRP, CF (200 UG) | 200 UG | 3,060.00 |
| R&D | 1708-PI-050 | Recombinant Human Lipocalin-1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1709-ML-025 | Recombinant Mouse IL-17B (25 UG) | 25 UG | 4,150.00 |
| R&D | 1709-ML-025/CF | Recombinant Mouse IL-17B, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 17105-1 | Recombinant Porcine IFN-alpha (Mammalian) (100000 UN) | 100000 UN | 4,490.00 |
| R&D | 1714-CN-025 | Recombinant Human Contactin-2/TAG1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1718-CL-050 | Recombinant Human CLEC-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1719-SE-010 | Recombinant Human Kallikrein 4/Prostase, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1720-DM-050 | Recombinant Human Desmoglein-3 Fc Chimera, CF (50 UG) | 50 UG | 4,280.00 |
| R&D | 1724-SE-020 | Recombinant Human Complement MASP3 Catalytic Domain, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1725-PI-050 | Recombinant Human Fetuin B, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1726-JG-050 | Recombinant Human Jagged 2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1728-S3-050 | Recombinant Mouse Semaphorin 3C Fc Chimera (Truncated), CF (50 UG) | 50 UG | 4,230.00 |
| R&D | 1729-T2-050 | Recombinant Mouse TREM-2b Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1737-MS-010 | Recombinant Human MIS/AMH (10 UG) | 10 UG | 4,150.00 |
| R&D | 1737-MS-010/CF | Recombinant Human MIS/AMH, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1738-FN-050 | Recombinant Mouse Follistatin-like 1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 174-TC-050 | Recombinant Human TACI/TNFRSF13B Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1744-CR-200 | Recombinant Rat C-Reactive Protein/CRP (200 UG) | 200 UG | 3,060.00 |
| R&D | 1744-CR-200/CF | Recombinant Rat C-Reactive Protein/CRP, CF (200 UG) | 200 UG | 3,060.00 |
| R&D | 1747-PI-010 | Recombinant Human Trappin-2/Elafin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1749-RB-050 | Recombinant Rat ROBO1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 175-TK-050 | Recombinant Human TrkA Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1750-TM-050 | Recombinant Human TIM-1/KIM-1/HAVCR, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1756-DC-050 | Recombinant Mouse Dectin-1/CLEC7A, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1757-LC-050 | Recombinant Human Lipocalin-2/NGAL, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 176-GB-025 | Recombinant Human CXCL2/GRO beta (aa 39-107) (25 UG) | 25 UG | 3,500.00 |
| R&D | 176-GB-025/CF | Recombinant Human CXCL2/GRO beta (aa 39-107), CF (25 UG) | 25 UG | 3,500.00 |
| R&D | 1760-RL-010 | Recombinant Rat IL-12 (10 UG) | 10 UG | 3,760.00 |
| R&D | 1760-RL-010/CF | Recombinant Rat IL-12, CF (10 UG) | 10 UG | 3,760.00 |
| R&D | 1764-KR-025 | Recombinant Mouse Kremen-2 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1764-KR-025/CF | Recombinant Mouse Kremen-2, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1765-DK-010 | Recombinant Mouse Dkk-1 (Histidine-tagged) (10 UG) | 10 UG | 4,150.00 |
| R&D | 1765-DK-010/CF | Recombinant Mouse Dkk-1 (Histidine-tagged), CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 177-IR-100 | Recombinant Human IL-17 RA/IL-17 R Fc Chimera, CF (100 UG) | 100 UG | 4,230.00 |
| R&D | 1774-MC-025 | Recombinant Canine CCL2/MCP-1 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1774-MC-025/CF | Recombinant Canine CCL2/MCP-1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1775-KS-010 | Recombinant Human Active Akt1, CF (10 UG) | 10 UG | 4,360.00 |
| R&D | 1776-KS-010 | Recombinant Mouse Active JNK1, CF (10 UG) | 10 UG | 4,360.00 |
| R&D | 1784-ZN-010 | Recombinant Human ECE-1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1785-MP-010 | Recombinant Human MMP-16/MT3-MMP, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1786-PI-010 | Recombinant Human Serpin E1/PAI-1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1787-MD-050 | Recombinant Human MD-2 (50 UG) | 50 UG | 4,150.00 |
| R&D | 1787-MD-050/CF | Recombinant Human MD-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1788-IR-050 | Recombinant Human IL-20 R beta Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1789-ML-025 | Recombinant Mouse IL-28B/IFN-lambda 3 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1789-ML-025/CF | Recombinant Mouse IL-28B/IFN-lambda 3, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1790-CA-050 | Recombinant Human Cadherin-11 (CAD-11) Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1794-LT-025 | Recombinant Mouse LIGHT/TNFSF14 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1794-LT-025/CF | Recombinant Mouse LIGHT/TNFSF14, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1795-FL-010 | Recombinant Feline IL-5 (10 UG) | 10 UG | 3,060.00 |
| R&D | 1795-FL-010/CF | Recombinant Feline IL-5, CF (10 UG) | 10 UG | 3,060.00 |
| R&D | 1796-FL-010 | Recombinant Feline IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3,760.00 |
| R&D | 1796-FL-010/CF | Recombinant Feline IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3,760.00 |
| R&D | 1797-MS-050 | Recombinant Mouse SR-AI/MSR1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1798-LX-050 | Recombinant Human LOX-1/OLR1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1806-T5-050 | Recombinant Human ILT5/CD85a Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1807-SE-010 | Recombinant Human Complement Component C1r, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1808-NR-050 | Recombinant Human Chordin-Like 1 (50 UG) | 50 UG | 4,150.00 |
| R&D | 1808-NR-050/CF | Recombinant Human Chordin-Like 1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1809-EL-020 | Recombinant Equine IL-4 (20 UG) | 20 UG | 4,360.00 |
| R&D | 1809-EL-020/CF | Recombinant Equine IL-4, CF (20 UG) | 20 UG | 4,360.00 |
| R&D | 1810-EC-050 | Recombinant Human Endocan (50 UG) | 50 UG | 4,150.00 |
| R&D | 1810-EC-050/CF | Recombinant Human Endocan, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1814-ET-025 | Recombinant Equine TNF-alpha (25 UG) | 25 UG | 4,150.00 |
| R&D | 1814-ET-025/CF | Recombinant Equine TNF-alpha, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1815-CL-020 | Recombinant Canine IL-2 (Cys147Ser) (20 UG) | 20 UG | 4,150.00 |
| R&D | 1815-CL-020/CF | Recombinant Canine IL-2 (Cys147Ser), CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1816-DT-050 | Recombinant Mouse DcTRAIL R2/TNFRSF22 (50 UG) | 50 UG | 4,490.00 |
| R&D | 1816-DT-050/CF | Recombinant Mouse DcTRAIL R2/TNFRSF22, CF (50 UG) | 50 UG | 4,490.00 |
| R&D | 1817-TM-050 | Recombinant Mouse TIM-1/KIM-1/HAVCR (50 UG) | 50 UG | 4,150.00 |
| R&D | 1817-TM-050/CF | Recombinant Mouse TIM-1/KIM-1/HAVCR, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1818-DL-050 | Recombinant Human DLL1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1819-KL-050 | Recombinant Mouse Klotho (aa 35-982), CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1820-SB-050 | Recombinant Human S100B, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1824-SE-010 | Recombinant Human Complement Factor D, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1826-TS-025 | Recombinant Human Pentraxin 3/TSG-14 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1826-TS-025/CF | Recombinant Human Pentraxin 3/TSG-14, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1827-SF-025 | Recombinant Human sFRP-4 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1827-SF-025/CF | Recombinant Human sFRP-4, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1828-T2-050 | Recombinant Human TREM-2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1829-CR-200 | Recombinant Mouse C-Reactive Protein/CRP, CF (200 UG) | 200 UG | 3,060.00 |
| R&D | 1830-SR-025 | Recombinant Mouse IL-6 R alpha (aa 20-357) (25 UG) | 25 UG | 4,150.00 |
| R&D | 1830-SR-025/CF | Recombinant Mouse IL-6 R alpha (aa 20-357), CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1835-S3-050 | Recombinant Mouse Semaphorin 7A Fc Chimera, CF (50 UG) | 50 UG | 4,230.00 |
| R&D | 1836-SR-050 | Recombinant Mouse SIGNR1/CD209b Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1845-SH-100 | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus (100 UG) | 100 UG | 9,480.00 |
| R&D | 1845-SH-025 | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus (25 UG) | 25 UG | 3,890.00 |
| R&D | 1845-SH-500 | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus (500 UG) | 500 UG | 24,570.00 |
| R&D | 1845-SH-100/CF | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus, CF (100 UG) | 100 UG | 9,480.00 |
| R&D | 1845-SH-025/CF | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus, CF (25 UG) | 25 UG | 3,890.00 |
| R&D | 1847-KR-050 | Recombinant Human KIR2DS4/CD158i Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1849-NK-025 | Recombinant Human NKp30 Fc Chimera, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 185-OS-025 | Recombinant Human Osteoprotegerin/TNFRSF11B (25 UG) | 25 UG | 4,800.00 |
| R&D | 185-OS-025/CF | Recombinant Human Osteoprotegerin/TNFRSF11B, CF (25 UG) | 25 UG | 4,800.00 |
| R&D | 1850-NK-025 | Recombinant Human NKp46/NCR1 Fc Chimera, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1855-CD-050 | Recombinant Human CD84/SLAMF5 (50 UG) | 50 UG | 4,150.00 |
| R&D | 1855-CD-050/CF | Recombinant Human CD84/SLAMF5, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1857-LC-050 | Recombinant Mouse Lipocalin-2/NGAL, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1859-DC-050 | Recombinant Human Dectin-1/CLEC7A, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1860-AM-050 | Recombinant Human Amnionless, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1865-SE-010 | Recombinant Mouse Granzyme B, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1866-CD-050 | Recombinant Mouse CD47 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1869-HP-025 | Recombinant Human HPRG, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1870-IL-010 | Recombinant Human IL-26/AK155 Dimer (10 UG) | 10 UG | 4,150.00 |
| R&D | 1870-IL-010/CF | Recombinant Human IL-26/AK155 Dimer, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1875-CD-050 | Recombinant Human FC gamma RIIB/C (CD32b/c), CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1878-SH-010 | Recombinant Human Active SHP-1 (aa 205-595), CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1879-KS-010 | Recombinant Human Active ERK1, CF (10 UG) | 10 UG | 4,360.00 |
| R&D | 188-C8-005 | Recombinant Human Cadherin-8 (CAD-8) Fc Chimera, CF (5 UG) | 5 UG | 3,890.00 |
| R&D | 1885-TM-050 | Recombinant Mouse TIM-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1886-EL-025 | Recombinant Equine IL-6 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1886-EL-025/CF | Recombinant Equine IL-6, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1887-ML-010 | Recombinant Mouse IL-23 (10 UG) | 10 UG | 4,150.00 |
| R&D | 1887-ML-010/CF | Recombinant Mouse IL-23, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1888-LM-050 | Recombinant Mouse LIMPII/SR-B2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1889-PI-010 | Recombinant Human Cystatin F, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1890-FL-020 | Recombinant Feline IL-2 (Cys146Ser) (20 UG) | 20 UG | 4,150.00 |
| R&D | 1890-FL-020/CF | Recombinant Feline IL-2 (Cys146Ser), CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1894-SH-100 | Recombinant Human Active SHP-2, CF (100 UG) | 100 UG | 4,150.00 |
| R&D | 1895-SA-050 | Recombinant Rat Pentraxin 2/SAP (50 UG) | 50 UG | 4,150.00 |
| R&D | 1895-SA-050/CF | Recombinant Rat Pentraxin 2/SAP, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1896-TL-010 | Recombinant Mouse TL1A/TNFSF15 (10 UG) | 10 UG | 4,150.00 |
| R&D | 1896-TL-010/CF | Recombinant Mouse TL1A/TNFSF15, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1898-CD-050 | Recombinant Human CD229/SLAMF3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1899-FR-050 | Recombinant Mouse FGF R5 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1900-NK-050 | Recombinant Human NKp80/KLRF1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1904-SC-025 | Recombinant Human SCGF-alpha/CLEC11a (25 UG) | 25 UG | 4,150.00 |
| R&D | 1904-SC-025/CF | Recombinant Human SCGF-alpha/CLEC11a, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1905-HP-025 | Recombinant Mouse HPRG, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1907-BL-050 | Recombinant Human BLAME/SLAMF8, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1908-NT-050 | Recombinant Human NTB-A/SLAMF6 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 191-ED-010 | Recombinant Mouse EDA-A1/Ectodysplasin A1 (10 UG) | 10 UG | 4,150.00 |
| R&D | 191-ED-010/CF | Recombinant Mouse EDA-A1/Ectodysplasin A1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1915-MF-050 | Recombinant Human MFRP, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1917-CM-050 | Recombinant Human CRIM1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1918-FN-02M | Human Fibronectin, CF (2 MG) | 2 MG | 3,320.00 |
| R&D | 192-SF-010 | Recombinant Human sFRP-3 (10 UG) | 10 UG | 4,150.00 |
| R&D | 192-SF-010/CF | Recombinant Human sFRP-3, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1920-SP-050 | Recombinant Human SP-D, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1927-ZN-010 | Recombinant Human BMP-1/PCP, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1928-SE-010 | Recombinant Mouse Spinesin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 193-BC-050 | Recombinant Human BCMA/TNFRSF17 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1930-PT-050 | Recombinant Human TC-PTP (aa 2-314), CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1934-DP-010 | Recombinant Human DEP-1/CD148 (aa 997-1337), CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1936-SE-010 | Recombinant Human Complement Component C2, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1937-SE-020 | Recombinant Mouse Tryptase beta-1/Mcpt7, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 1938-PI-050 | Human alpha 2-Macroglobulin, CF (50 UG) | 50 UG | 1,940.00 |
| R&D | 1939-SE-200 | Human Plasminogen, CF (200 UG) | 200 UG | 1,940.00 |
| R&D | 194-FZ-050 | Recombinant Mouse Frizzled-4 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1945-RL-025 | Recombinant Rat IL-13 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1945-RL-025/CF | Recombinant Rat IL-13, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1946-KR-025 | Recombinant Human Kremen-2 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1946-KR-025/CF | Recombinant Human Kremen-2, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1947-MS-050 | Recombinant Human MSP R/Ron, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1948-SA-050 | Recombinant Human Pentraxin 2/SAP (50 UG) | 50 UG | 4,150.00 |
| R&D | 1948-SA-050/CF | Recombinant Human Pentraxin 2/SAP, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1949-B3-050 | Recombinant Human B7-H3 (50 UG) | 50 UG | 4,150.00 |
| R&D | 1949-B3-050/CF | Recombinant Human B7-H3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1950-M5-050 | Recombinant Human ICAM-5 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1954-FL-025 | Recombinant Feline IL-12 (25 UG) | 25 UG | 4,620.00 |
| R&D | 1954-FL-025/CF | Recombinant Feline IL-12, CF (25 UG) | 25 UG | 4,620.00 |
| R&D | 1955-CD-050 | Recombinant Human CD36/SR-B3 Fc Chimera, CF (50 UG) | 50 UG | 4,360.00 |
| R&D | 1956-CV-050 | Recombinant Human Crossveinless-2 (50 UG) | 50 UG | 4,150.00 |
| R&D | 1956-CV-050/CF | Recombinant Human Crossveinless-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1957-KG-025 | Recombinant Canine KGF/FGF-7 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1957-KG-025/CF | Recombinant Canine KGF/FGF-7, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1958-GD-010 | Recombinant Human GDF-11/BMP-11 (10 UG) | 10 UG | 4,360.00 |
| R&D | 1958-GD-010/CF | Recombinant Human GDF-11/BMP-11, CF (10 UG) | 10 UG | 4,360.00 |
| R&D | 1959-B2-050 | Recombinant Human IL-12 R beta 2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1960-FC-050 | Recombinant Mouse Fc gamma RIII/CD16, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1964-CL-025 | Recombinant Canine IL-5 (25 UG) | 25 UG | 3,760.00 |
| R&D | 1964-CL-025/CF | Recombinant Canine IL-5, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 1965-IL-025 | Recombinant Human IL-24 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1965-IL-025/CF | Recombinant Human IL-24, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1966-LM-050 | Recombinant Human LIMPII/SR-B2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1967-NG-025 | Recombinant Mouse Noggin (25 UG) | 25 UG | 4,410.00 |
| R&D | 1967-NG-025/CF | Recombinant Mouse Noggin, CF (25 UG) | 25 UG | 4,410.00 |
| R&D | 1968-SL-050 | Recombinant Human Siglec-2/CD22 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1969-CL-025 | Recombinant Canine IL-12/IL-23 p40 (25 UG) | 25 UG | 4,620.00 |
| R&D | 1969-CL-025/CF | Recombinant Canine IL-12/IL-23 p40, CF (25 UG) | 25 UG | 4,620.00 |
| R&D | 1970-TX-500 | Recombinant Human Thioredoxin-1, CF (500 UG) | 500 UG | 4,150.00 |
| R&D | 1974-CD-050 | Recombinant Mouse FcgR4/CD16-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1975-IL-025 | Recombinant Human IL-1F7/FIL1 zeta, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1976-NV-050 | Recombinant Mouse NOV/CCN3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1977-MR-050 | Recombinant Human IL-11 R alpha Fc Chimera, CF (50 UG) | 50 UG | 4,360.00 |
| R&D | 1978-MF-025 | Recombinant Mouse MIF (25 UG) | 25 UG | 2,930.00 |
| R&D | 1978-MF-025/CF | Recombinant Mouse MIF, CF (25 UG) | 25 UG | 2,930.00 |
| R&D | 198-FZ-050 | Recombinant Mouse Frizzled-7 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1986-CB-025 | Recombinant Mouse Cerberus 1 (25 UG) | 25 UG | 4,150.00 |
| R&D | 1986-CB-025/CF | Recombinant Mouse Cerberus 1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 1987-CD-050 | Recombinant Human CD59, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 1988-SE-010 | Recombinant Human Marapsin/Pancreasin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1989-SE-010 | Recombinant Mouse Marapsin/Pancreasin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 1998-B1-050 | Recombinant Mouse IL-12 R beta 1, CF (50 UG) | 50 UG | 4,280.00 |
| R&D | 1999-EC-050 | Recombinant Mouse Endocan, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 200-LA-010 | Recombinant Human IL-1 alpha/IL-1F1 (10 UG) | 10 UG | 7,920.00 |
| R&D | 200-LA-002 | Recombinant Human IL-1 alpha/IL-1F1 (2 UG) | 2 UG | 2,330.00 |
| R&D | 200-LA-010/CF | Recombinant Human IL-1 alpha/IL-1F1, CF (10 UG) | 10 UG | 7,920.00 |
| R&D | 200-LA-002/CF | Recombinant Human IL-1 alpha/IL-1F1, CF (2 UG) | 2 UG | 2,330.00 |
| R&D | 2009-CD-050 | Recombinant Human CD55/DAF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2009-CD-050/CF | Recombinant Human CD55/DAF, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 201-GMP-01M | Recombinant Human IL-1 beta/IL-1F2 GMP, CF (1 MG) | 1 MG | 71,500.00 |
| R&D | 201-GMP-025 | Recombinant Human IL-1 beta/IL-1F2 GMP, CF (25 UG) | 25 UG | 14,300.00 |
| R&D | 201-GMP-005 | Recombinant Human IL-1 beta/IL-1F2 GMP, CF (5 UG) | 5 UG | 4,280.00 |
| R&D | 201-LB-025 | Recombinant Human IL-1 beta/IL-1F2 (25 UG) | 25 UG | 11,040.00 |
| R&D | 201-LB-005 | Recombinant Human IL-1 beta/IL-1F2 (5 UG) | 5 UG | 3,320.00 |
| R&D | 201-LB-025/CF | Recombinant Human IL-1 beta/IL-1F2, CF (25 UG) | 25 UG | 11,040.00 |
| R&D | 201-LB-500/CF | Recombinant Human IL-1 beta/IL-1F2, CF (500 UG) | 500 UG | 32,500.00 |
| R&D | 201-LB-005/CF | Recombinant Human IL-1 beta/IL-1F2, CF (5 UG) | 5 UG | 3,320.00 |
| R&D | 2014-KR-050 | Recombinant Human KIR2DL3/CD158b2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2017-T2-050 | Recombinant Human ILT2/CD85j Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 202-IL-010 | Recombinant Human IL-2 (10 UG) | 10 UG | 2,590.00 |
| R&D | 202-IL-500 | Recombinant Human IL-2 (500 UG) | 500 UG | 11,570.00 |
| R&D | 202-IL-050 | Recombinant Human IL-2 (50 UG) | 50 UG | 8,130.00 |
| R&D | 202-IL-010/CF | Recombinant Human IL-2, CF (10 UG) | 10 UG | 2,590.00 |
| R&D | 202-IL-050/CF | Recombinant Human IL-2, CF (50 UG) | 50 UG | 8,130.00 |
| R&D | 2025-SE-010 | Recombinant Human Kallikrein 8/Neuropsin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2026-EM-050 | Recombinant Mouse Pro-EMAP-II, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2028-EG-200 | Recombinant Mouse EGF, CF (200 UG) | 200 UG | 3,060.00 |
| R&D | 203-GMP-010 | Recombinant Human IL-3 GMP, CF (10 UG) | 10 UG | 3,060.00 |
| R&D | 203-GMP-01M | Recombinant Human IL-3 GMP, CF (1 MG) | 1 MG | 55,900.00 |
| R&D | 203-GMP-050 | Recombinant Human IL-3 GMP, CF (50 UG) | 50 UG | 9,430.00 |
| R&D | 203-IL-010 | Recombinant Human IL-3 (10 UG) | 10 UG | 2,330.00 |
| R&D | 203-IL-050 | Recombinant Human IL-3 (50 UG) | 50 UG | 7,270.00 |
| R&D | 203-IL-010/CF | Recombinant Human IL-3, CF (10 UG) | 10 UG | 2,330.00 |
| R&D | 203-IL-050/CF | Recombinant Human IL-3, CF (50 UG) | 50 UG | 7,270.00 |
| R&D | 2034-NR-050 | Recombinant Human NrCAM Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2036-BC-050 | Recombinant Human BOC, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2037-C5-025 | Recombinant Human Complement Component C5a (25 UG) | 25 UG | 3,760.00 |
| R&D | 2037-C5-025/CF | Recombinant Human Complement Component C5a, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 204-GMP-010 | Recombinant Human IL-4 GMP, CF (10 UG) | 10 UG | 3,450.00 |
| R&D | 204-GMP-01M | Recombinant Human IL-4 GMP, CF (1 MG) | 1 MG | 71,500.00 |
| R&D | 204-GMP-050 | Recombinant Human IL-4 GMP, CF (50 UG) | 50 UG | 11,510.00 |
| R&D | 204-IL-010 | Recombinant Human IL-4 (10 UG) | 10 UG | 2,670.00 |
| R&D | 204-IL-050 | Recombinant Human IL-4 (50 UG) | 50 UG | 8,830.00 |
| R&D | 204-IL-010/CF | Recombinant Human IL-4, CF (10 UG) | 10 UG | 2,670.00 |
| R&D | 204-IL-001MG/CF | Recombinant Human IL-4, CF (1 MG) | 1 MG | 55,900.00 |
| R&D | 204-IL-050/CF | Recombinant Human IL-4, CF (50 UG) | 50 UG | 8,830.00 |
| R&D | 2044-CD-050 | Recombinant Human CD83 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2045-GA-050 | Recombinant Human Galectin-9, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2048-FC-050 | Recombinant Human FCRL2/FcRH2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2049-FC-050 | Recombinant Human FCRL1/FcRH1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 205-IL-025 | Recombinant Human IL-5 (25 UG) | 25 UG | 7,140.00 |
| R&D | 205-IL-005 | Recombinant Human IL-5 (5 UG) | 5 UG | 2,280.00 |
| R&D | 205-IL-025/CF | Recombinant Human IL-5, CF (25 UG) | 25 UG | 7,140.00 |
| R&D | 205-IL-005/CF | Recombinant Human IL-5, CF (5 UG) | 5 UG | 2,280.00 |
| R&D | 2057-IL-025 | Recombinant Mouse IL-17F (25 UG) | 25 UG | 4,150.00 |
| R&D | 2057-IL-025/CF | Recombinant Mouse IL-17F, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2058-CY-010 | Recombinant Mouse Legumain/Asparaginyl Endopeptidase, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2059-SE-010 | Recombinant Mouse Tryptase epsilon/BSSP-4, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 206-GMP-010 | Recombinant Human IL-6 GMP, CF (10 UG) | 10 UG | 3,900.00 |
| R&D | 206-GMP-01M | Recombinant Human IL-6 GMP, CF (1 MG) | 1 MG | 57,200.00 |
| R&D | 206-GMP-050 | Recombinant Human IL-6 GMP, CF (50 UG) | 50 UG | 12,350.00 |
| R&D | 206-IL-010 | Recombinant Human IL-6 (10 UG) | 10 UG | 2,980.00 |
| R&D | 206-IL-050 | Recombinant Human IL-6 (50 UG) | 50 UG | 9,480.00 |
| R&D | 206-IL-010/CF | Recombinant Human IL-6, CF (10 UG) | 10 UG | 2,980.00 |
| R&D | 206-IL-001MG/CF | Recombinant Human IL-6, CF (1 MG) | 1 MG | 44,200.00 |
| R&D | 206-IL-050/CF | Recombinant Human IL-6, CF (50 UG) | 50 UG | 9,480.00 |
| R&D | 2060-SE-010 | Recombinant Human Complement Component C1s, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2068-S7-050 | Recombinant Human Semaphorin 7A Fc Chimera, CF (50 UG) | 50 UG | 4,230.00 |
| R&D | 2069-PR-050 | Recombinant Mouse PRDC/GREM2 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2069-PR-050/CF | Recombinant Mouse PRDC/GREM2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 207-GMP-01M | Recombinant Human IL-7 GMP, CF (1 MG) | 1 MG | 87,750.00 |
| R&D | 207-GMP-025 | Recombinant Human IL-7 GMP, CF (25 UG) | 25 UG | 12,030.00 |
| R&D | 207-IL-025 | Recombinant Human IL-7 (25 UG) | 25 UG | 9,300.00 |
| R&D | 207-IL-005 | Recombinant Human IL-7 (5 UG) | 5 UG | 2,930.00 |
| R&D | 207-IL-025/CF | Recombinant Human IL-7, CF (25 UG) | 25 UG | 9,300.00 |
| R&D | 207-IL-005/CF | Recombinant Human IL-7, CF (5 UG) | 5 UG | 2,930.00 |
| R&D | 2070-GS-025 | Recombinant Human GASP-1/WFIKKNRP (25 UG) | 25 UG | 4,150.00 |
| R&D | 2070-GS-025/CF | Recombinant Human GASP-1/WFIKKNRP, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2074-FC-050 | Recombinant Mouse Fc gamma RI/CD64, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2077-MB-050 | Recombinant Mouse MBL-1 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2077-MB-050/CF | Recombinant Mouse MBL-1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2078-FC-050 | Recombinant Human FCRL5/FcRH5, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2078-T4-050 | Recombinant Human ILT4/CD85d Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 208-IL-010 | Recombinant Human CXCL8/IL-8 (10 UG) | 10 UG | 1,890.00 |
| R&D | 208-IL-050 | Recombinant Human CXCL8/IL-8 (50 UG) | 50 UG | 6,050.00 |
| R&D | 208-IL-010/CF | Recombinant Human CXCL8/IL-8, CF (10 UG) | 10 UG | 1,890.00 |
| R&D | 208-IL-050/CF | Recombinant Human CXCL8/IL-8, CF (50 UG) | 50 UG | 6,050.00 |
| R&D | 2080-AM-050 | Recombinant Human AMIGO2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2088-LN-050 | Recombinant Human Langerin/CD207, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2089-LY-025 | Recombinant Human LYVE-1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 209-IL-010 | Recombinant Human IL-9 (10 UG) | 10 UG | 4,150.00 |
| R&D | 209-IL-050 | Recombinant Human IL-9 (50 UG) | 50 UG | 11,900.00 |
| R&D | 209-IL-010/CF | Recombinant Human IL-9, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 209-IL-050/CF | Recombinant Human IL-9, CF (50 UG) | 50 UG | 11,900.00 |
| R&D | 2094-S6-050 | Recombinant Human Semaphorin 6B Fc Chimera, CF (50 UG) | 50 UG | 4,230.00 |
| R&D | 2095-S6-050 | Recombinant Human Semaphorin 6D Fc Chimera, CF (50 UG) | 50 UG | 4,230.00 |
| R&D | 2098-RG-050 | Recombinant Mouse Reg2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2099-FB-025 | Recombinant Bovine FGF basic (25 UG) | 25 UG | 2,930.00 |
| R&D | 2099-FB-025/CF | Recombinant Bovine FGF basic, CF (25 UG) | 25 UG | 2,930.00 |
| R&D | 210-GMP-100 | Recombinant Human TNF-alpha GMP, CF (100 UG) | 100 UG | 10,600.00 |
| R&D | 210-GMP-020 | Recombinant Human TNF-alpha GMP, CF (20 UG) | 20 UG | 3,450.00 |
| R&D | 210-GMP-02M | Recombinant Human TNF-alpha GMP, CF (2 MG) | 2 MG | 33,800.00 |
| R&D | 210-TA-100 | Recombinant Human TNF-alpha (100 UG) | 100 UG | 8,180.00 |
| R&D | 210-TA-020 | Recombinant Human TNF-alpha (20 UG) | 20 UG | 2,670.00 |
| R&D | 210-TA-005 | Recombinant Human TNF-alpha (5 UG) | 5 UG | 1,240.00 |
| R&D | 210-TA-100/CF | Recombinant Human TNF-alpha, CF (100 UG) | 100 UG | 8,180.00 |
| R&D | 210-TA-020/CF | Recombinant Human TNF-alpha, CF (20 UG) | 20 UG | 2,670.00 |
| R&D | 210-TA-02M/CF | Recombinant Human TNF-alpha, CF (2 MG) | 2 MG | 26,070.00 |
| R&D | 210-TA-005/CF | Recombinant Human TNF-alpha, CF (5 UG) | 5 UG | 1,240.00 |
| R&D | 2104-TS-050 | Recombinant Human TSG-6, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2105-VI-100 | Recombinant Human Vimentin, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 2106-BF-010 | Recombinant Mouse BAFF/BLyS/TNFSF13B (10 UG) | 10 UG | 2,930.00 |
| R&D | 2106-BF-010/CF | Recombinant Mouse BAFF/BLyS/TNFSF13B, CF (10 UG) | 10 UG | 2,930.00 |
| R&D | 2108-S6-050 | Recombinant Mouse Semaphorin 6C, CF (50 UG) | 50 UG | 4,230.00 |
| R&D | 2109-TC-050 | Recombinant Mouse IL-27 Ra/WSX-1/TCCR Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 211-TB-010 | Recombinant Human TNF-beta/TNFSF1 (10 UG) | 10 UG | 2,930.00 |
| R&D | 211-TB-050 | Recombinant Human TNF-beta/TNFSF1 (50 UG) | 50 UG | 9,300.00 |
| R&D | 211-TB-010/CF | Recombinant Human TNF-beta/TNFSF1, CF (10 UG) | 10 UG | 2,930.00 |
| R&D | 211-TB-050/CF | Recombinant Human TNF-beta/TNFSF1, CF (50 UG) | 50 UG | 9,300.00 |
| R&D | 2110-WN-010 | Recombinant Mouse Wnt-10b (10 UG) | 10 UG | 4,150.00 |
| R&D | 2110-WN-010/CF | Recombinant Mouse Wnt-10b, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 21100-1 | Human IFN-alpha MAb (Clone MMHA-2) (50 UG) | 50 UG | 4,100.00 |
| R&D | 21100-2 | Human IFN-alpha MAb (Clone MMHA-2) (500 UG) | 500 UG | 6,620.00 |
| R&D | 21105-1 | Human IFN-alpha MAb (Clone MMHA-1) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21110-1 | Human IFN-alpha MAb (Clone MMHA-8) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21112-1 | Human IFN-alpha MAb (Clone MMHA-11) (50 UG) | 50 UG | 3,580.00 |
| R&D | 21112-3 | Human IFN-alpha Fluorescein Mab (Clone MMHA-11) (50 TESTS) | 50 TESTS | 4,490.00 |
| R&D | 21116-1 | Human IFN-alpha MAb (Clone MMHA-13) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21118-1 | Human IFN-alpha MAb (Clone MMHA-17) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21125-1 | Human IFN-alpha MAb (Clone MMHA-6) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21127-1 | Human IFN-alpha MAb (Clone MMHA-9) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21129-1 | Human IFN-alpha MAb (Clone MMHA-14) (50 UG) | 50 UG | 2,590.00 |
| R&D | 2117-FL-025 | Recombinant Feline IL-12/IL-23 p40 (25 UG) | 25 UG | 4,620.00 |
| R&D | 2117-FL-025/CF | Recombinant Feline IL-12/IL-23 p40, CF (25 UG) | 25 UG | 4,620.00 |
| R&D | 2118-CL-025 | Recombinant Canine IL-12 (25 UG) | 25 UG | 4,620.00 |
| R&D | 2118-CL-025/CF | Recombinant Canine IL-12, CF (25 UG) | 25 UG | 4,620.00 |
| R&D | 2119-GP-050 | Recombinant Human Glypican 3 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2119-GP-050/CF | Recombinant Human Glypican 3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 212-GD-010 | Recombinant Human GDNF (10 UG) | 10 UG | 3,890.00 |
| R&D | 212-GD-050 | Recombinant Human GDNF (50 UG) | 50 UG | 12,730.00 |
| R&D | 212-GD-010/CF | Recombinant Human GDNF, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 212-GD-050/CF | Recombinant Human GDNF, CF (50 UG) | 50 UG | 12,730.00 |
| R&D | 2120-B7-025 | Recombinant Mouse IGFBP-rp1/IGFBP-7, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2125-LY-025 | Recombinant Mouse LYVE-1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2126-CH-025 | Recombinant Human CHL-1/L1CAM-2, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2128-GA-050 | Recombinant Mouse Galectin-4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 213-ILB-025 | Recombinant Human IL-13 (25 UG) | 25 UG | 12,290.00 |
| R&D | 213-ILB-005 | Recombinant Human IL-13 (5 UG) | 5 UG | 3,840.00 |
| R&D | 213-ILB-01MG/CF | Recombinant Human IL-13, CF (1 MG) | 1 MG | 74,100.00 |
| R&D | 213-ILB-025/CF | Recombinant Human IL-13, CF (25 UG) | 25 UG | 12,290.00 |
| R&D | 213-ILB-005/CF | Recombinant Human IL-13, CF (5 UG) | 5 UG | 3,840.00 |
| R&D | 2130-SL-050 | Recombinant Human Siglec-10 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2136-GS-025 | Recombinant Human GASP-2/WFIKKN (25 UG) | 25 UG | 4,230.00 |
| R&D | 2136-GS-025/CF | Recombinant Human GASP-2/WFIKKN, CF (25 UG) | 25 UG | 4,230.00 |
| R&D | 21385-1 | Human IFN-alpha/beta R2 Mab (Clone MMHAR-2) (50 UG) | 50 UG | 5,400.00 |
| R&D | 21385-3 | Human IFN-alpha/beta R2 Phycoerythrin MAb (Clone MMHAR-2) (50 TESTS) | 50 TESTS | 5,400.00 |
| R&D | 21395-1 | Human IFN-omega MAb (Clone OMG-4) (100 UG) | 100 UG | 3,970.00 |
| R&D | 214-CS-025 | Recombinant Human G-CSF (25 UG) | 25 UG | 9,300.00 |
| R&D | 214-CS-005 | Recombinant Human G-CSF (5 UG) | 5 UG | 2,850.00 |
| R&D | 214-CS-025/CF | Recombinant Human G-CSF, CF (25 UG) | 25 UG | 9,300.00 |
| R&D | 214-CS-005/CF | Recombinant Human G-CSF, CF (5 UG) | 5 UG | 2,850.00 |
| R&D | 21400-1 | Human IFN-beta MAb (Clone MMHB-3) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21400-3 | Human IFN-beta Fluorescein MAb (Clone MMHB-3) (50 TESTS) | 50 TESTS | 3,580.00 |
| R&D | 21405-1 | Human IFN-beta MAb (Clone MMHB-1) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21450-1 | Human IFN-beta MAb (Clone MMHB-12) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21455-1 | Human IFN-beta MAb (Clone MMHB-13) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21460-1 | Human IFN-beta MAb (Clone MMHB-14) (50 UG) | 50 UG | 2,590.00 |
| R&D | 21465-1 | Human IFN-beta MAb (Clone MMHB-15) (50 UG) | 50 UG | 2,590.00 |
| R&D | 2147-CH-025 | Recombinant Mouse CHL-1/L1CAM-2, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 21470-1 | Human IFN-beta MAb (Clone MMHB-16) (50 UG) | 50 UG | 2,590.00 |
| R&D | 2148-HP-025 | Recombinant Human LDL R (High Purity), CF (25 UG) | 25 UG | 5,010.00 |
| R&D | 2148-LD-025 | Recombinant Human LDL R (25 UG) | 25 UG | 4,150.00 |
| R&D | 2148-LD-025/CF | Recombinant Human LDL R, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2149-BF-010 | Recombinant Human BAFF/BLyS/TNFSF13B (10 UG) | 10 UG | 2,930.00 |
| R&D | 2149-BF-010/CF | Recombinant Human BAFF/BLyS/TNFSF13B, CF (10 UG) | 10 UG | 2,930.00 |
| R&D | 215-GM-010 | Recombinant Human GM-CSF (10 UG) | 10 UG | 2,850.00 |
| R&D | 215-GM-500 | Recombinant Human GM-CSF (500 UG) | 500 UG | 24,570.00 |
| R&D | 215-GM-050 | Recombinant Human GM-CSF (50 UG) | 50 UG | 10,390.00 |
| R&D | 215-GM-010/CF | Recombinant Human GM-CSF, CF (10 UG) | 10 UG | 2,850.00 |
| R&D | 215-GM-050/CF | Recombinant Human GM-CSF, CF (50 UG) | 50 UG | 10,390.00 |
| R&D | 215-GMP-010 | Recombinant Human GM-CSF GMP, CF (10 UG) | 10 UG | 3,710.00 |
| R&D | 215-GMP-01M | Recombinant Human GM-CSF GMP, CF (1 MG) | 1 MG | 54,600.00 |
| R&D | 215-GMP-050 | Recombinant Human GM-CSF GMP, CF (50 UG) | 50 UG | 13,460.00 |
| R&D | 2150-C5-025 | Recombinant Mouse Complement Component C5a (25 UG) | 25 UG | 3,760.00 |
| R&D | 2150-C5-025/CF | Recombinant Mouse Complement Component C5a, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 2154-B7-050 | Recombinant Mouse B7-H4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2159-FA-050 | Recombinant Rat Fas/TNFRSF6/CD95 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 216-MC-025 | Recombinant Human M-CSF (25 UG) | 25 UG | 6,570.00 |
| R&D | 216-MC-500 | Recombinant Human M-CSF (500 UG) | 500 UG | 32,240.00 |
| R&D | 216-MC-005 | Recombinant Human M-CSF (5 UG) | 5 UG | 2,070.00 |
| R&D | 216-MC-025/CF | Recombinant Human M-CSF, CF (25 UG) | 25 UG | 6,570.00 |
| R&D | 216-MC-005/CF | Recombinant Human M-CSF, CF (5 UG) | 5 UG | 2,070.00 |
| R&D | 216-MCC-010 | Recombinant Human M-CSF (CHO-expressed) (10 UG) | 10 UG | 4,150.00 |
| R&D | 216-MCC-010/CF | Recombinant Human M-CSF (CHO-expressed), CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2166-TS-025 | Recombinant Mouse Pentraxin 3/TSG-14 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2166-TS-025/CF | Recombinant Mouse Pentraxin 3/TSG-14, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 217-IL-025 | Recombinant Human IL-10 (25 UG) | 25 UG | 11,640.00 |
| R&D | 217-IL-005 | Recombinant Human IL-10 (5 UG) | 5 UG | 3,890.00 |
| R&D | 217-IL-025/CF | Recombinant Human IL-10, CF (25 UG) | 25 UG | 11,640.00 |
| R&D | 217-IL-005/CF | Recombinant Human IL-10, CF (5 UG) | 5 UG | 3,890.00 |
| R&D | 2175-PI-010 | Recombinant Mouse Serpin E2/PN1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2177-GL-025 | Recombinant Mouse GITR Ligand/TNFSF18 (aa 47-173) (25 UG) | 25 UG | 4,150.00 |
| R&D | 2177-GL-025/CF | Recombinant Mouse GITR Ligand/TNFSF18 (aa 47-173), CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2179-VC-025 | Recombinant Human VEGF-C (25 UG) | 25 UG | 4,150.00 |
| R&D | 2179-VC-025/CF | Recombinant Human VEGF-C, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 218-IL-025 | Recombinant Human IL-11 (25 UG) | 25 UG | 10,990.00 |
| R&D | 218-IL-005 | Recombinant Human IL-11 (5 UG) | 5 UG | 3,370.00 |
| R&D | 218-IL-025/CF | Recombinant Human IL-11, CF (25 UG) | 25 UG | 10,990.00 |
| R&D | 218-IL-005/CF | Recombinant Human IL-11, CF (5 UG) | 5 UG | 3,370.00 |
| R&D | 2180-CA-050 | Recombinant Human Carbonic Anhydrase I, CF (50 UG) | 50 UG | 3,500.00 |
| R&D | 2184-CA-050 | Recombinant Human Carbonic Anhydrase II, CF (50 UG) | 50 UG | 3,500.00 |
| R&D | 2185-CA-050 | Recombinant Human Carbonic Anhydrase III, CF (50 UG) | 50 UG | 3,500.00 |
| R&D | 2186-CA-010 | Recombinant Human Carbonic Anhydrase IV, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 2187-CA-050 | Recombinant Human Carbonic Anhydrase VIII, CF (50 UG) | 50 UG | 3,500.00 |
| R&D | 2188-CA-010 | Recombinant Human Carbonic Anhydrase IX, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 2189-CA-010 | Recombinant Human Carbonic Anhydrase X/CA10, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 219-IL-025 | Recombinant Human IL-12 (25 UG) | 25 UG | 12,550.00 |
| R&D | 219-IL-005 | Recombinant Human IL-12 (5 UG) | 5 UG | 3,890.00 |
| R&D | 219-IL-025/CF | Recombinant Human IL-12, CF (25 UG) | 25 UG | 12,550.00 |
| R&D | 219-IL-005/CF | Recombinant Human IL-12, CF (5 UG) | 5 UG | 3,890.00 |
| R&D | 2190-CA-010 | Recombinant Human Carbonic Anhydrase XII, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 2194-CA-050 | Recombinant Human Carbonic Anhydrase XIII, CF (50 UG) | 50 UG | 3,500.00 |
| R&D | 2195-CA-010 | Recombinant Human Carbonic Anhydrase XIV, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 2196-SE-200 | Human Coagulation Factor II/Thrombin, CF (200 UG) | 200 UG | 1,940.00 |
| R&D | 2197-AD-020 | Recombinant Human ADAMTS1, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 2198-AD-020 | Recombinant Human ADAMTS5, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 2199-CY-010 | Recombinant Human Legumain/Asparaginyl Endopeptidase, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 220-BB-010 | Recombinant Human PDGF-BB, CF (10 UG) | 10 UG | 3,320.00 |
| R&D | 220-BB-01M | Recombinant Human PDGF-BB, CF (1 MG) | 1 MG | 55,250.00 |
| R&D | 220-BB-050 | Recombinant Human PDGF-BB, CF (50 UG) | 50 UG | 10,390.00 |
| R&D | 2200-SE-050 | Recombinant Human Azurocidin/CAP37/HBP (50 UG) | 50 UG | 4,150.00 |
| R&D | 2200-SE-050/CF | Recombinant Human Azurocidin/CAP37/HBP, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2205-CN-025 | Recombinant Human Contactin-4, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2206-PI-010 | Recombinant Mouse Kininogen HMW (HKa), CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2207-HG-025 | Recombinant Mouse HGF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2207-HG-025/CF | Recombinant Mouse HGF, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2208-MB-050 | Recombinant Mouse MBL-2 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2208-MB-050/CF | Recombinant Mouse MBL-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 221-AA-010 | Recombinant Human PDGF-AA, CF (10 UG) | 10 UG | 3,320.00 |
| R&D | 221-AA-050 | Recombinant Human PDGF-AA, CF (50 UG) | 50 UG | 10,390.00 |
| R&D | 22100-1 | Mouse IFN-alpha MAb (Clone RMMA-1) (250 UG) | 250 UG | 5,400.00 |
| R&D | 22100-3 | Mouse IFN-alpha Fluorescein Mab (Clone RMMA-1) (25 UG) | 25 UG | 5,060.00 |
| R&D | 2215-N2-025 | Recombinant Human Neuropilin-2 Fc Chimera, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2217-CA-050 | Recombinant Human Cadherin-4/R-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2219-S6-050 | Recombinant Human Semaphorin 6C Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 222-AB-010 | Recombinant Human PDGF-AB, CF (10 UG) | 10 UG | 3,320.00 |
| R&D | 222-AB-050 | Recombinant Human PDGF-AB, CF (50 UG) | 50 UG | 10,390.00 |
| R&D | 2225-NK-050 | Recombinant Mouse NKp46/NCR1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2226-GA-050 | Recombinant Human Galectin-3BP/MAC-2BP, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2229-N2-050 | Recombinant Human Nectin-2/CD112 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2229-N2-050/CF | Recombinant Human Nectin-2/CD112, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 223-2A-025 | Recombinant Human IL-2 R alpha (25 UG) | 25 UG | 7,270.00 |
| R&D | 223-2A-005 | Recombinant Human IL-2 R alpha (5 UG) | 5 UG | 2,330.00 |
| R&D | 223-2A-025/CF | Recombinant Human IL-2 R alpha, CF (25 UG) | 25 UG | 7,270.00 |
| R&D | 223-2A-005/CF | Recombinant Human IL-2 R alpha, CF (5 UG) | 5 UG | 2,330.00 |
| R&D | 2237-SE-010 | Recombinant Human Tripeptidyl-peptidase I/TPP1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2238-KR-050 | Recombinant Human KIR2DL4/CD158d Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2239-PE-020 | Recombinant Mouse PCPE-1, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 224-2B-025 | Recombinant Human IL-2 R beta (25 UG) | 25 UG | 7,270.00 |
| R&D | 224-2B-005 | Recombinant Human IL-2 R beta (5 UG) | 5 UG | 2,330.00 |
| R&D | 224-2B-025/CF | Recombinant Human IL-2 R beta, CF (25 UG) | 25 UG | 7,270.00 |
| R&D | 224-2B-005/CF | Recombinant Human IL-2 R beta, CF (5 UG) | 5 UG | 2,330.00 |
| R&D | 2240-CA-050 | Recombinant Human Cadherin-12 (CAD-12) Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 22400-1 | Mouse IFN-beta MAb (Clone RMMB-1) (250 UG) | 250 UG | 4,280.00 |
| R&D | 22400-3 | Mouse IFN-beta Fluorescein Mab (Clone RMMB-1) (100 UL) | 100 UL | 4,280.00 |
| R&D | 2244-CM-050 | Recombinant Human CEACAM-1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2246-FG-025 | Recombinant Human FGF-12 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2246-FG-025/CF | Recombinant Human FGF-12, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2249-NK-050 | Recombinant Human NKp44 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2254-DN-050 | Recombinant Mouse DNER Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2255-LD-025 | Recombinant Mouse LDL R (25 UG) | 25 UG | 4,150.00 |
| R&D | 2255-LD-025/CF | Recombinant Mouse LDL R, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2258-VL-050 | Recombinant Mouse VLDL R (Ser297), CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2265-FR-050 | Recombinant Mouse FGF R4 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2267-FA-050 | Recombinant Feline Fas/TNFRSF6/CD95 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2268-SC-025 | Recombinant Feline SCF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2268-SC-025/CF | Recombinant Feline SCF, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2269-IL-050 | Recombinant Human IL-17 RC, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 227-SR-025 | Recombinant Human IL-6 R alpha (25 UG) | 25 UG | 4,930.00 |
| R&D | 227-SR-025/CF | Recombinant Human IL-6 R alpha, CF (25 UG) | 25 UG | 4,930.00 |
| R&D | 2270-ML-050 | Recombinant Mouse IL-17 RC, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2274-ML-025 | Recombinant Mouse IL-17D (25 UG) | 25 UG | 4,150.00 |
| R&D | 2274-ML-025/CF | Recombinant Mouse IL-17D, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2275-IL-050 | Recombinant Human IL-17 RD/SEF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2275-IL-050/CF | Recombinant Human IL-17 RD/SEF, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2275-PC-100 | Human GAPDH/G3PDH Polyclonal Ab (100 UL) | 100 UL | 3,760.00 |
| R&D | 2276-ML-050 | Recombinant Mouse IL-17 RD/SEF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2276-ML-050/CF | Recombinant Mouse IL-17 RD/SEF, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2277-FL-025 | Recombinant Feline CXCL8/IL-8 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2277-FL-025/CF | Recombinant Feline CXCL8/IL-8, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2278-SC-025 | Recombinant Canine SCF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2278-SC-025/CF | Recombinant Canine SCF, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2279-BT-025 | Recombinant Bovine TNF-alpha (25 UG) | 25 UG | 3,760.00 |
| R&D | 2279-BT-025/CF | Recombinant Bovine TNF-alpha, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 228-GP-010 | Recombinant Human Soluble gp130 (10 UG) | 10 UG | 3,890.00 |
| R&D | 228-GP-050 | Recombinant Human Soluble gp130 (50 UG) | 50 UG | 12,730.00 |
| R&D | 228-GP-010/CF | Recombinant Human Soluble gp130, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 228-GP-050/CF | Recombinant Human Soluble gp130, CF (50 UG) | 50 UG | 12,730.00 |
| R&D | 2281-MC-100 | Human/Mouse/Rat Bax MAb (Clone YTH-6A7) (100 UG) | 100 UG | 3,760.00 |
| R&D | 2282-MC-100 | Human Bax MAb (Clone YTH-2D2) (100 UG) | 100 UG | 3,760.00 |
| R&D | 229-PE-010 | Recombinant Human PD-ECGF/Thymidine Phosphorylase (10 UG) | 10 UG | 3,060.00 |
| R&D | 229-PE-050 | Recombinant Human PD-ECGF/Thymidine Phosphorylase (50 UG) | 50 UG | 10,600.00 |
| R&D | 229-PE-010/CF | Recombinant Human PD-ECGF/Thymidine Phosphorylase, CF (10 UG) | 10 UG | 3,060.00 |
| R&D | 229-PE-050/CF | Recombinant Human PD-ECGF/Thymidine Phosphorylase, CF (50 UG) | 50 UG | 10,600.00 |
| R&D | 2291-MC-100 | Human Bcl-2 MAb (Clone YTH-8C8) (100 UG) | 100 UG | 3,760.00 |
| R&D | 2295-4L-025 | Recombinant Human 4-1BB Ligand/TNFSF9 (25 UG) | 25 UG | 3,320.00 |
| R&D | 2295-4L-025/CF | Recombinant Human 4-1BB Ligand/TNFSF9, CF (25 UG) | 25 UG | 3,320.00 |
| R&D | 2296-SL-050 | Recombinant Mouse Siglec-2/CD22 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2297-ML-025 | Recombinant Mouse IL-36 alpha/IL-1F6 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2297-ML-025/CF | Recombinant Mouse IL-36 alpha/IL-1F6, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2298-ML-025 | Recombinant Mouse IL-36 beta/IL-1F8 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2298-ML-025/CF | Recombinant Mouse IL-36 beta/IL-1F8, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2299-CV-050 | Recombinant Mouse Crossveinless-2 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2299-CV-050/CF | Recombinant Mouse Crossveinless-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 230-4R-025 | Recombinant Human IL-4 R alpha (25 UG) | 25 UG | 5,530.00 |
| R&D | 230-4R-025/CF | Recombinant Human IL-4 R alpha, CF (25 UG) | 25 UG | 5,530.00 |
| R&D | 230-4RB-025 | Recombinant Human IL-4 R alpha, CF (25 UG) | 25 UG | 5,530.00 |
| R&D | 2300-BG-025 | Recombinant Bovine IFN-gamma (25 UG) | 25 UG | 3,760.00 |
| R&D | 2300-BG-025/CF | Recombinant Bovine IFN-gamma, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 2300-MC-100 | Human/Mouse/Rat Bcl-xL MAb (Clone YTH-2H12) (100 UG) | 100 UG | 3,760.00 |
| R&D | 2304-GP-050 | Recombinant Human Glypican 2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2305-FL-025 | Recombinant Feline IL-6 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2305-FL-025/CF | Recombinant Feline IL-6, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2306-ML-025 | Recombinant Mouse IL-17C (25 UG) | 25 UG | 4,150.00 |
| R&D | 2306-ML-025/CF | Recombinant Mouse IL-17C, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2307-MB-050 | Recombinant Human MBL (50 UG) | 50 UG | 4,150.00 |
| R&D | 2307-MB-050/CF | Recombinant Human MBL, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2308-VN-050 | Recombinant Human Vitronectin, CF (50 UG) | 50 UG | 2,930.00 |
| R&D | 231-BC-025 | Recombinant Human FGF acidic (aa 2-155) (25 UG) | 25 UG | 3,060.00 |
| R&D | 231-BC-025/CF | Recombinant Human FGF acidic (aa 2-155), CF (25 UG) | 25 UG | 3,060.00 |
| R&D | 2318-B3-050 | Recombinant Human B7-H3 (4Ig)/B7-H3b (50 UG) | 50 UG | 4,150.00 |
| R&D | 2318-B3-050/CF | Recombinant Human B7-H3 (4Ig)/B7-H3b, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2319-L3-050 | Recombinant Human LAG-3 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 232-FA-025 | Recombinant Human FGF acidic (aa 16-155) (25 UG) | 25 UG | 2,330.00 |
| R&D | 232-FA-025/CF | Recombinant Human FGF acidic (aa 16-155), CF (25 UG) | 25 UG | 2,330.00 |
| R&D | 2320-IL-025 | Recombinant Human IL-36 gamma/IL-1F9 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2320-IL-025/CF | Recombinant Human IL-36 gamma/IL-1F9, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2324-CM-025 | Recombinant Human Chemerin (25 UG) | 25 UG | 4,150.00 |
| R&D | 2324-CM-025/CF | Recombinant Human Chemerin, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2325-CM-025 | Recombinant Mouse Chemerin (aa 17-156) (25 UG) | 25 UG | 4,150.00 |
| R&D | 2325-CM-025/CF | Recombinant Mouse Chemerin (aa 17-156), CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2326-TS-050 | Recombinant Mouse TSG-6, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2327-PI-050 | Recombinant Human Testican 1/SPOCK1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2328-PI-050 | Recombinant Human Testican 2/SPOCK2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2329-TX-100 | Recombinant Human Thioredoxin 80, CF (100 UG) | 100 UG | 3,760.00 |
| R&D | 233-FB-01M | Recombinant Human FGF basic (146 aa) (1 MG) | 1 MG | Please Inquire |
| R&D | 233-FB-025 | Recombinant Human FGF basic (146 aa) (25 UG) | 25 UG | 2,410.00 |
| R&D | 233-FB-001MG/CF | Recombinant Human FGF basic (146 aa), CF (1 MG) | 1 MG | Please Inquire |
| R&D | 233-FB-025/CF | Recombinant Human FGF basic (146 aa), CF (25 UG) | 25 UG | 2,410.00 |
| R&D | 233-GMP-01M | Recombinant Human FGF basic (146 aa) GMP, CF (1 MG) | 1 MG | Please Inquire |
| R&D | 233-GMP-025 | Recombinant Human FGF basic (146 aa) GMP, CF (25 UG) | 25 UG | 3,120.00 |
| R&D | 2330-AC-050 | Recombinant Mouse Osteoactivin/GPNMB Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2334-ZN-010 | Recombinant Human Aminopeptidase PILS/ARTS1, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 2335-ZN-010 | Recombinant Mouse Aminopeptidase N/ANPEP, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2336-CY-010 | Recombinant Mouse Active Cathepsin C/DPPI, CF (10 UG) | 10 UG | 4,800.00 |
| R&D | 2337-SE-010 | Recombinant Human Kallikrein 1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2338-SE-010 | Recombinant Human Coagulation Factor VII, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2339-PA-010 | Recombinant Human Coagulation Factor III/Tissue Factor, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 234-FSE-025 | Recombinant Human FGF basic (157 aa) (25 UG) | 25 UG | 3,320.00 |
| R&D | 234-FSE-025/CF | Recombinant Human FGF basic (157 aa), CF (25 UG) | 25 UG | 3,320.00 |
| R&D | 2340-ZN-010 | Recombinant Human Neprilysin-2/MMEL1, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2344-CA-010 | Recombinant Mouse Carbonic Anhydrase IX, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 2345-CA-010 | Recombinant Mouse Carbonic Anhydrase XII, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 2346-PI-050 | Recombinant Mouse Testican 3/SPOCK3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2347-VE-025 | Recombinant Human VEGF 162 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2347-VE-025/CF | Recombinant Human VEGF 162, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2348-VN-100 | Bovine Vitronectin, CF (100 UG) | 100 UG | 3,240.00 |
| R&D | 2349-VN-100 | Human Vitronectin, CF (100 UG) | 100 UG | 3,240.00 |
| R&D | 235-F4-025 | Recombinant Human FGF-4 (25 UG) | 25 UG | 3,320.00 |
| R&D | 235-F4-025/CF | Recombinant Human FGF-4, CF (25 UG) | 25 UG | 3,320.00 |
| R&D | 2354-RP-100 | Recombinant Mouse IL-1 Rrp2/IL-1 R6 (100 UG) | 100 UG | 4,230.00 |
| R&D | 2354-RP-100/CF | Recombinant Mouse IL-1 Rrp2/IL-1 R6, CF (100 UG) | 100 UG | 4,230.00 |
| R&D | 2355-GP-050 | Recombinant Mouse Glypican 2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 236-EG-01M | Recombinant Human EGF, CF (1 MG) | 1 MG | 5,320.00 |
| R&D | 236-EG-200 | Recombinant Human EGF, CF (200 UG) | 200 UG | 1,680.00 |
| R&D | 236-GMP-01M | Recombinant Human EGF GMP, CF (1 MG) | 1 MG | 6,880.00 |
| R&D | 236-GMP-200 | Recombinant Human EGF GMP, CF (200 UG) | 200 UG | 2,200.00 |
| R&D | 2364-ER-050 | Recombinant Human Endorepellin, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2365-TM-050 | Recombinant Human TIM-3 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2366-RB-050 | Recombinant Human ROBO4 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2367-FC-050 | Recombinant Human Ficolin-3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2368-L2-050 | Recombinant Human LRP-1 Cluster II Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 237-F5-050 | Recombinant Human FGF-5 (50 UG) | 50 UG | 2,670.00 |
| R&D | 237-F5-050/CF | Recombinant Human FGF-5, CF (50 UG) | 50 UG | 2,670.00 |
| R&D | 2376-BP-025 | Recombinant Mouse IL-22BP Fc Chimera, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2379-CD-050 | Recombinant Human C1q R1/CD93 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 238-F6-025 | Recombinant Human FGF-6 (25 UG) | 25 UG | 3,320.00 |
| R&D | 238-F6-025/CF | Recombinant Human FGF-6, CF (25 UG) | 25 UG | 3,320.00 |
| R&D | 2380-CR-025 | Recombinant Human CREG (25 UG) | 25 UG | 4,150.00 |
| R&D | 2380-CR-025/CF | Recombinant Human CREG, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2388-PS-010 | Recombinant Human Persephin (10 UG) | 10 UG | 4,150.00 |
| R&D | 2388-PS-010/CF | Recombinant Human Persephin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 239-A-100 | Recombinant Human TGF-alpha, CF (100 UG) | 100 UG | 4,150.00 |
| R&D | 239-A-500 | Recombinant Human TGF-alpha, CF (500 UG) | 500 UG | 12,940.00 |
| R&D | 2390-TH-050 | Recombinant Human Thrombospondin-4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2396-DR-050 | Recombinant Human DDR1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2397-CR-050 | Recombinant Human CRISP-3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 240-B-010 | Recombinant Human TGF-beta 1 (10 UG) | 10 UG | 10,520.00 |
| R&D | 240-B-002 | Recombinant Human TGF-beta 1 (2 UG) | 2 UG | 3,320.00 |
| R&D | 240-B-010/CF | Recombinant Human TGF-beta 1, CF (10 UG) | 10 UG | 10,520.00 |
| R&D | 240-B-001MG/CF | Recombinant Human TGF-beta 1, CF (1 MG) | 1 MG | Please Inquire |
| R&D | 240-B-002/CF | Recombinant Human TGF-beta 1, CF (2 UG) | 2 UG | 3,320.00 |
| R&D | 240-GMP-010 | Recombinant Human TGF-beta 1 GMP, CF (10 UG) | 10 UG | 12,090.00 |
| R&D | 240-GMP-01M | Recombinant Human TGF-beta 1 GMP, CF (1 MG) | 1 MG | Please Inquire |
| R&D | 240-GMP-002 | Recombinant Human TGF-beta 1 GMP, CF (2 UG) | 2 UG | 3,840.00 |
| R&D | 2404-AC-010 | Recombinant Human CD38, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 2406-BR-100 | Recombinant Human BMPR-IA/ALK-3 Fc Chimera, CF (100 UG) | 100 UG | 5,270.00 |
| R&D | 2408-NC-050 | Recombinant Human NCAM-1/CD56, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2409-SR-050 | Recombinant Human SREC-I/SCARF1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 241-R2-025 | Recombinant Human TGF-beta RII (25 UG) | 25 UG | 4,490.00 |
| R&D | 241-R2-025/CF | Recombinant Human TGF-beta RII, CF (25 UG) | 25 UG | 4,490.00 |
| R&D | 2414-CA-010 | Recombinant Mouse Carbonic Anhydrase IV, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 2415-CR-025 | Recombinant Human CLC/CNTF R alpha Chimera (25 UG) | 25 UG | 4,150.00 |
| R&D | 2415-CR-025/CF | Recombinant Human CLC/CNTF R alpha Chimera, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 242-R3-100 | Recombinant Human TGF-beta RIII (100 UG) | 100 UG | 6,570.00 |
| R&D | 242-R3-100/CF | Recombinant Human TGF-beta RIII, CF (100 UG) | 100 UG | 6,570.00 |
| R&D | 2420-PG-050 | Recombinant Human Progranulin, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2424-TL-050 | Recombinant Mouse TREML1/TLT-1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2428-FC-050 | Recombinant Human Ficolin-2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 243-B3-010 | Recombinant Human TGF-beta 3 (10 UG) | 10 UG | 13,770.00 |
| R&D | 243-B3-002 | Recombinant Human TGF-beta 3 (2 UG) | 2 UG | 4,280.00 |
| R&D | 243-B3-010/CF | Recombinant Human TGF-beta 3, CF (10 UG) | 10 UG | 13,770.00 |
| R&D | 243-B3-002/CF | Recombinant Human TGF-beta 3, CF (2 UG) | 2 UG | 4,280.00 |
| R&D | 2435-DK-010 | Recombinant Mouse Dkk-2 (10 UG) | 10 UG | 4,150.00 |
| R&D | 2435-DK-010/CF | Recombinant Mouse Dkk-2, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2437-D3-050 | Recombinant Mouse DR3/TNFRSF25 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2438-RM-050 | Recombinant Mouse IL-2 R alpha, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2440-FZ-050 | Recombinant Mouse Frizzled-9 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2445-NG-050 | Recombinant Rat Nogo-A Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2446-CH-050 | Recombinant Mouse Chitinase 3-like 3/ECF-L, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2447-GR-050 | Recombinant Human IGF-II R, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2449-SU-020 | Recombinant Human Iduronate 2-Sulfatase, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 245-AB-050 | Recombinant Human IFN-alpha/beta R1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 245-B5-010 | Recombinant Amphibian TGF-beta 5 (10 UG) | 10 UG | 11,120.00 |
| R&D | 245-B5-002 | Recombinant Amphibian TGF-beta 5 (2 UG) | 2 UG | 4,230.00 |
| R&D | 245-B5-010/CF | Recombinant Amphibian TGF-beta 5, CF (10 UG) | 10 UG | 11,120.00 |
| R&D | 245-B5-002/CF | Recombinant Amphibian TGF-beta 5, CF (2 UG) | 2 UG | 4,230.00 |
| R&D | 2458-RG-050 | Recombinant Mouse RGM-A, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2459-RM-050 | Recombinant Human RGM-A, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 246-LP-025 | Recombinant Human LAP (TGF-beta 1) (25 UG) | 25 UG | 4,670.00 |
| R&D | 246-LP-025/CF | Recombinant Human LAP (TGF-beta 1), CF (25 UG) | 25 UG | 4,670.00 |
| R&D | 2460-SE-010 | Recombinant Human Coagulation Factor XI, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2464-EV-025 | Recombinant Mouse EG-VEGF/PK1 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2464-EV-025/CF | Recombinant Mouse EG-VEGF/PK1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2465-BL-020 | Recombinant Bovine IL-2 (20 UG) | 20 UG | 3,760.00 |
| R&D | 2465-BL-020/CF | Recombinant Bovine IL-2, CF (20 UG) | 20 UG | 3,760.00 |
| R&D | 2466-RA-050 | Recombinant Equine IL-1ra/IL-1F3 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2466-RA-050/CF | Recombinant Equine IL-1ra/IL-1F3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2467-FL-025 | Recombinant Feline Flt-3 Ligand (25 UG) | 25 UG | 4,150.00 |
| R&D | 2467-FL-025/CF | Recombinant Feline Flt-3 Ligand, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2469-BL-025 | Recombinant Bovine IL-4 (25 UG) | 25 UG | 3,890.00 |
| R&D | 2469-BL-025/CF | Recombinant Bovine IL-4, CF (25 UG) | 25 UG | 3,890.00 |
| R&D | 247-IL-025 | Recombinant Human IL-15 (25 UG) | 25 UG | 8,650.00 |
| R&D | 247-IL-005 | Recombinant Human IL-15 (5 UG) | 5 UG | 2,930.00 |
| R&D | 247-IL-025/CF | Recombinant Human IL-15, CF (25 UG) | 25 UG | 8,650.00 |
| R&D | 247-IL-005/CF | Recombinant Human IL-15, CF (5 UG) | 5 UG | 2,930.00 |
| R&D | 2470-EL-025 | Recombinant Equine IL-5 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2470-EL-025/CF | Recombinant Equine IL-5, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2474-TR-050 | Recombinant Human TfR, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2479-PS-010 | Recombinant Mouse Persephin (10 UG) | 10 UG | 4,150.00 |
| R&D | 2479-PS-010/CF | Recombinant Mouse Persephin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 248-BD-01M | Recombinant Human BDNF (1 MG) | 1 MG | Please Inquire |
| R&D | 248-BD-025 | Recombinant Human BDNF (25 UG) | 25 UG | 8,650.00 |
| R&D | 248-BD-005 | Recombinant Human BDNF (5 UG) | 5 UG | 2,930.00 |
| R&D | 248-BD-025/CF | Recombinant Human BDNF, CF (25 UG) | 25 UG | 8,650.00 |
| R&D | 248-BD-005/CF | Recombinant Human BDNF, CF (5 UG) | 5 UG | 2,930.00 |
| R&D | 2484-SUC-010 | Recombinant Human Glucosamine (N-Acetyl)-6-Sulfatase, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2485-SU-020 | Recombinant Human Arylsulfatase A/ARSA, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 2486-SU-020 | Recombinant Mouse Iduronate 2-sulfatase, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 2487-ZN-020 | Recombinant Human Pappalysin-1/PAPP-A (aa 82-1214), CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 2487-ZNF-020 | Recombinant Human Pappalysin-1/PAPP-A (aa 82-1627), CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 2488-PI-200 | Human Serpin G1/C1 Inhibitor (Plasma), CF (200 UG) | 200 UG | 3,320.00 |
| R&D | 2489-ZN-010 | Recombinant Human Carnosine Dipeptidase 1, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 249-LR-050/CF | Recombinant Human LIF R alpha, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2490-ZN-010 | Recombinant Human Aminopeptidase P2/XPNPEP2, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2494-ZN-010 | Recombinant Mouse Aminopeptidase P2/XPNPEP2, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2495-SE-010 | Recombinant Human Spinesin, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2496-ZN-010 | Recombinant Human Insulysin/IDE, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2497-SE-010 | Recombinant Human Plasma Kallikrein/KLKB1, CF (10 UG) | 10 UG | 3,060.00 |
| R&D | 2498-SE-010 | Recombinant Mouse Plasma Kallikrein/KLKB1, CF (10 UG) | 10 UG | 3,060.00 |
| R&D | 2499-ZN-010 | Recombinant Human Aminopeptidase A/ENPEP, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2500-ZN-010 | Recombinant Mouse Aminopeptidase PILS/ARTS1, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 2504-CA-010 | Recombinant Mouse Carbonic Anhydrase XIV, CF (10 UG) | 10 UG | 3,500.00 |
| R&D | 2506-KS-010 | Recombinant Human Active GSK-3 beta, CF (10 UG) | 10 UG | 4,360.00 |
| R&D | 251-GMP-010 | Recombinant Human KGF/FGF-7 GMP, CF (10 UG) | 10 UG | 4,360.00 |
| R&D | 251-GMP-01M | Recombinant Human KGF/FGF-7 GMP, CF (1 MG) | 1 MG | Please Inquire |
| R&D | 251-GMP-050 | Recombinant Human KGF/FGF-7 GMP, CF (50 UG) | 50 UG | 12,940.00 |
| R&D | 251-KG-010 | Recombinant Human KGF/FGF-7 (10 UG) | 10 UG | 3,760.00 |
| R&D | 251-KG-050 | Recombinant Human KGF/FGF-7 (50 UG) | 50 UG | 11,250.00 |
| R&D | 251-KG-010/CF | Recombinant Human KGF/FGF-7, CF (10 UG) | 10 UG | 3,760.00 |
| R&D | 251-KG-050/CF | Recombinant Human KGF/FGF-7, CF (50 UG) | 50 UG | 11,250.00 |
| R&D | 2516-HV-100 | Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (100 UG) | 100 UG | 4,490.00 |
| R&D | 2519-CD-050 | Recombinant Mouse CD36/SR-B3 Fc Chimera, CF (50 UG) | 50 UG | 4,360.00 |
| R&D | 252-PL-250 | Recombinant Human Pleiotrophin/PTN, CF (250 UG) | 250 UG | 10,780.00 |
| R&D | 252-PL-050 | Recombinant Human Pleiotrophin/PTN, CF (50 UG) | 50 UG | 3,760.00 |
| R&D | 2520-CH-050 | Recombinant Mouse Chordin-Like 2 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2520-CH-050/CF | Recombinant Mouse Chordin-Like 2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2524-RL-025 | Recombinant Rat IL-3 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2524-RL-025/CF | Recombinant Rat IL-3, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2525-BL-025 | Recombinant Bovine IL-5 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2525-BL-025/CF | Recombinant Bovine IL-5, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2526-IL-010 | Recombinant Human IL-27 (10 UG) | 10 UG | 4,150.00 |
| R&D | 2526-IL-010/CF | Recombinant Human IL-27, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2527-SR-050 | Recombinant Human SREC-II/SCARF2 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2528-AV-050 | Recombinant Human Integrin alpha V beta 5, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2529-CD-050 | Recombinant Human CD97, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 253-5R-025 | Recombinant Human IL-5 R alpha (25 UG) | 25 UG | 5,530.00 |
| R&D | 253-5R-025/CF | Recombinant Human IL-5 R alpha, CF (25 UG) | 25 UG | 5,530.00 |
| R&D | 2530-CD-050 | Recombinant Human CD155/PVR (50 UG) | 50 UG | 4,150.00 |
| R&D | 2530-CD-050/CF | Recombinant Human CD155/PVR, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2534-MR-050 | Recombinant Human MMR/CD206 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2534-MR-050/CF | Recombinant Human MMR/CD206, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2535-MM-050 | Recombinant Mouse MMR/CD206 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2535-MM-050/CF | Recombinant Mouse MMR/CD206, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2536-GT-020 | Recombinant Mouse Exostosin-like 2, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 2536-LA-025 | Recombinant Human Layilin (25 UG) | 25 UG | 4,150.00 |
| R&D | 2536-LA-025/CF | Recombinant Human Layilin, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2538-DR-050 | Recombinant Human DDR2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2539-FG-025 | Recombinant Human FGF-21 (25 UG) | 25 UG | 3,760.00 |
| R&D | 2539-FG-025/CF | Recombinant Human FGF-21, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 254-XB-025 | Recombinant Human CXCL5/ENA-78 (25 UG) | 25 UG | 4,360.00 |
| R&D | 254-XB-025/CF | Recombinant Human CXCL5/ENA-78, CF (25 UG) | 25 UG | 4,360.00 |
| R&D | 2545-PI-010 | Recombinant Human TFPI-2, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2547-FG-025 | Recombinant Human FGF-20 (25 UG) | 25 UG | 3,760.00 |
| R&D | 2547-FG-025/CF | Recombinant Human FGF-20, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 2548-RM-025 | Recombinant Rhesus Macaque IL-18/IL-1F4 (25 UG) | 25 UG | 3,760.00 |
| R&D | 2548-RM-025/CF | Recombinant Rhesus Macaque IL-18/IL-1F4, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 255-SC-010 | Recombinant Human SCF (10 UG) | 10 UG | 2,590.00 |
| R&D | 255-SC-050 | Recombinant Human SCF (50 UG) | 50 UG | 7,790.00 |
| R&D | 255-SC-010/CF | Recombinant Human SCF, CF (10 UG) | 10 UG | 2,590.00 |
| R&D | 255-SC-001MG/CF | Recombinant Human SCF, CF (1 MG) | 1 MG | Please Inquire |
| R&D | 255-SC-050/CF | Recombinant Human SCF, CF (50 UG) | 50 UG | 7,790.00 |
| R&D | 2550-AC-050 | Recombinant Human Osteoactivin/GPNMB Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2554-CD-050 | Recombinant Mouse CD200 R1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2555-CD-050 | Recombinant Mouse CD229/SLAMF3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2557-PG-050 | Recombinant Mouse Progranulin, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2558-SA-050 | Recombinant Mouse Pentraxin 2/SAP, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2559-BG-050 | Recombinant Mouse beta IG-H3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 256-GF-100 | Recombinant Human beta-NGF (100 UG) | 100 UG | 3,760.00 |
| R&D | 256-GF-100/CF | Recombinant Human beta-NGF, CF (100 UG) | 100 UG | 3,760.00 |
| R&D | 2560-S7-050 | Recombinant Human ST7/LRP12, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2564-K2-050 | Recombinant Human Kirrel2/NEPH3, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2565-AM-050 | Recombinant Human AMIGO, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2568-EP-025 | Recombinant Mouse Epimorphin/Syntaxin 2, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 257-NT-010 | Recombinant Human CNTF (10 UG) | 10 UG | 2,670.00 |
| R&D | 257-NT-050 | Recombinant Human CNTF (50 UG) | 50 UG | 8,440.00 |
| R&D | 257-NT-010/CF | Recombinant Human CNTF, CF (10 UG) | 10 UG | 2,670.00 |
| R&D | 257-NT-050/CF | Recombinant Human CNTF, CF (50 UG) | 50 UG | 8,440.00 |
| R&D | 2570-ND-050 | Recombinant Human Nidogen-1/Entactin, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 258-MD-010 | Recombinant Human Midkine, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 258-MD-050 | Recombinant Human Midkine, CF (50 UG) | 50 UG | 12,550.00 |
| R&D | 2580-LM-050 | Recombinant Mouse CD300b/LMIR5 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2585-PG-050 | Recombinant Human NG2/MCSP/CSPG4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2586-FT-025 | Recombinant Feline TNF-alpha (25 UG) | 25 UG | 4,150.00 |
| R&D | 2586-FT-025/CF | Recombinant Feline TNF-alpha, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2587-SK-050 | Recombinant Human SLITRK5, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2588-MU-050 | Recombinant Mouse ULBP-1/MULT-1 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2588-MU-050/CF | Recombinant Mouse ULBP-1/MULT-1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2589-AR-025 | Recombinant Human Artemin (25 UG) | 25 UG | 4,150.00 |
| R&D | 2589-AR-025/CF | Recombinant Human Artemin, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 259-HE-250 | Recombinant Human HB-EGF (250 UG) | 250 UG | 7,270.00 |
| R&D | 259-HE-050 | Recombinant Human HB-EGF (50 UG) | 50 UG | 2,330.00 |
| R&D | 259-HE-250/CF | Recombinant Human HB-EGF, CF (250 UG) | 250 UG | 7,270.00 |
| R&D | 259-HE-050/CF | Recombinant Human HB-EGF, CF (50 UG) | 50 UG | 2,330.00 |
| R&D | 2590-PG-050 | Recombinant Human PGRP-S (50 UG) | 50 UG | 4,150.00 |
| R&D | 2590-PG-050/CF | Recombinant Human PGRP-S, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2595-VE-025 | Recombinant Mouse VEGF-B 167 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2595-VE-025/CF | Recombinant Mouse VEGF-B 167, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2597-CD-050 | Recombinant Feline sCD4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2599-CH-050 | Recombinant Human Chitinase 3-like 1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2604-FG-025 | Recombinant Human FGF-23 (25 UG) | 25 UG | 3,760.00 |
| R&D | 2604-FG-025/CF | Recombinant Human FGF-23, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 2607-G5-050 | Recombinant Human Glypican 5 (50 UG) | 50 UG | 4,150.00 |
| R&D | 2607-G5-050/CF | Recombinant Human Glypican 5, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2608-HP-025 | Recombinant Human HAPLN1, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 261-CE-010 | Recombinant Human Betacellulin (10 UG) | 10 UG | 3,890.00 |
| R&D | 261-CE-050 | Recombinant Human Betacellulin (50 UG) | 50 UG | 11,900.00 |
| R&D | 261-CE-010/CF | Recombinant Human Betacellulin, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 261-CE-050/CF | Recombinant Human Betacellulin, CF (50 UG) | 50 UG | 11,900.00 |
| R&D | 2616-TR-050 | Recombinant Human TLR2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2619-KB-050 | Recombinant Mouse Klotho beta, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 262-AR-100 | Recombinant Human Amphiregulin (100 UG) | 100 UG | 4,280.00 |
| R&D | 262-AR-100/CF | Recombinant Human Amphiregulin, CF (100 UG) | 100 UG | 4,280.00 |
| R&D | 2624-SE-010 | Recombinant Human Kallikrein 7, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2625-SE-010 | Recombinant Human Kallikrein 13, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2626-SE-010 | Recombinant Human Kallikrein 14, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2627-PE-020 | Recombinant Human PCPE-1, CF (20 UG) | 20 UG | 4,150.00 |
| R&D | 2629-FG-025 | Recombinant Mouse FGF-23 (25 UG) | 25 UG | 3,760.00 |
| R&D | 2629-FG-025/CF | Recombinant Mouse FGF-23, CF (25 UG) | 25 UG | 3,760.00 |
| R&D | 263-2R-050 | Recombinant Human IL-1 RII (50 UG) | 50 UG | 5,270.00 |
| R&D | 263-2R-050/CF | Recombinant Human IL-1 RII, CF (50 UG) | 50 UG | 5,270.00 |
| R&D | 2634-SE-010 | Recombinant Mouse Tryptase-5/Prss32, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 2636-GS-050 | Recombinant Human Gas1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2639-AO-010 | Recombinant Human Lysyl Oxidase Homolog 2, CF (10 UG) | 10 UG | 4,150.00 |
| R&D | 264-PG-010 | Recombinant Human PlGF (10 UG) | 10 UG | 3,890.00 |
| R&D | 264-PG-050 | Recombinant Human PlGF (50 UG) | 50 UG | 11,900.00 |
| R&D | 264-PG-010/CF | Recombinant Human PlGF, CF (10 UG) | 10 UG | 3,890.00 |
| R&D | 264-PG-050/CF | Recombinant Human PlGF, CF (50 UG) | 50 UG | 11,900.00 |
| R&D | 2640-LM-050 | Recombinant Human CD300a/LMIR1 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2644-GS-050 | Recombinant Mouse Gas1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2645-FR-050 | Recombinant Mouse GFR alpha-3 Fc Chimera, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2646-LA-025 | Recombinant Mouse Layilin, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2649-CH-050 | Recombinant Mouse Chitinase 3-like 1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 265-AN-250 | Recombinant Human Angiogenin (250 UG) | 250 UG | 12,940.00 |
| R&D | 265-AN-050 | Recombinant Human Angiogenin (50 UG) | 50 UG | 4,150.00 |
| R&D | 265-AN-250/CF | Recombinant Human Angiogenin, CF (250 UG) | 250 UG | 12,940.00 |
| R&D | 265-AN-050/CF | Recombinant Human Angiogenin, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2659-N4-050 | Recombinant Human Nectin-4, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 266-IP-010 | Recombinant Human CXCL10/IP-10 (10 UG) | 10 UG | 1,550.00 |
| R&D | 266-IP-050 | Recombinant Human CXCL10/IP-10 (50 UG) | 50 UG | 4,800.00 |
| R&D | 266-IP-010/CF | Recombinant Human CXCL10/IP-10, CF (10 UG) | 10 UG | 1,550.00 |
| R&D | 266-IP-050/CF | Recombinant Human CXCL10/IP-10, CF (50 UG) | 50 UG | 4,800.00 |
| R&D | 2664-LR-050 | Recombinant Human LAIR1, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2665-LR-050 | Recombinant Human LAIR2, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 2667-CM-050 | Recombinant Human Biglycan, CF (50 UG) | 50 UG | 4,150.00 |
| R&D | 267-GMP-01M | Recombinant Human NT-3 GMP, CF (1 MG) | 1 MG | Please Inquire |
| R&D | 267-GMP-025 | Recombinant Human NT-3 GMP, CF (25 UG) | 25 UG | 9,950.00 |
| R&D | 267-GMP-005 | Recombinant Human NT-3 GMP, CF (5 UG) | 5 UG | 3,370.00 |
| R&D | 267-N3-025 | Recombinant Human NT-3 (25 UG) | 25 UG | 8,650.00 |
| R&D | 267-N3-005 | Recombinant Human NT-3 (5 UG) | 5 UG | 2,930.00 |
| R&D | 267-N3-025/CF | Recombinant Human NT-3, CF (25 UG) | 25 UG | 8,650.00 |
| R&D | 267-N3-005/CF | Recombinant Human NT-3, CF (5 UG) | 5 UG | 2,930.00 |
| R&D | 2674-RM-025 | Recombinant Rhesus Macaque IL-13 (25 UG) | 25 UG | 4,150.00 |
| R&D | 2674-RM-025/CF | Recombinant Rhesus Macaque IL-13, CF (25 UG) | 25 UG | 4,150.00 |
| R&D | 2679-KS-010 | Recombinant Human Active Blk, CF (10 UG) | 10 UG | 4,360.00 |
| R&D | 268-N4-025 | Recombinant Human NT-4 (25 UG) | 25 UG | 8,650.00 |
| R&D | 268-N4-005 | Recombinant Human NT-4 (5 UG) | 5 UG | 2,930.00 |
| R&D | 268-N4-025/CF | Recombinant Human NT-4, CF (25 UG) | 25 UG | 8,650.00 |
上海起發(fā)實(shí)驗(yàn)試劑有限公司
：楊建輝
：
辦公：
*8006
:
:http://www.singlu.cn/
地址：上海市浦東新區(qū)繡川路561號(hào)1102室
產(chǎn)品咨詢
地址：上海浦東川沙鎮(zhèn)川沙路6619號(hào)上海起發(fā)實(shí)驗(yàn)試劑有限公司
郵箱：xs1@78bio.com
傳真：021-50724961
電話
微信
當(dāng)前位置：